Skip to main content
SpringerLink
Log in

Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In a double-blind, placebo-controlled study, the antidepressant and vigilance-promoting properties of transdermal oestrogen in post-menopausal depression were investigated utilizing hormonal, syndromal and EEG mapping evaluations. Sixty-nine menopausal women, aged 45–60 years without previous hormonal replacement therapy, diagnosed as major depression without psychotic or suicidal symptoms (DSM-III-R criteria), were randomly assigned to a 3-month treatment with transdermal oestradiol [Estraderm TTS (ETTS) 50 µg, applied twice weekly] or placebo. No other psychoactive medication was allowed. After removal of protocol violators, 32 patients were evaluable in each group, which did not differ in age, height or weight. As five patients discontinued prematurely in both groups and in one placebo patient a post-drug EEG could not be obtained, 27 patients remained in the ETTS and 26 in the placebo group for efficacy analysis. While in the placebo group, oestradiol (E2) and follicle stimulating hormone (FSH) remained unchanged, E2 increased and FSH decreased significantly in the ETTS group. Syndromal evaluation showed a significant improvement in the Kupperman Index (KI) as well as Hamilton Depression Rating Scale (HAMD) in both groups, with no inter-group difference. However, EEG mapping demonstrated significant interdrug differences in brain function, mostly over the left temporal region. While ETTS patients showed an increase of alpha and alpha-adjacent theta activity and a decrease of beta activity, as well as an acceleration of the delta/theta centroid and a slowing of the alpha, beta and total power centroid, no changes occurred in the placebo-treated patients. These neurophysiological findings suggest improvement of vigilance by oestrogen, previously referred to as “mental tonic” effect. There were no changes, however, in the frontal alpha asymmetry index, reflecting left frontal hypo- and right frontal hyperactivation. Thus, this neurophysiological variable represents a state-independent marker for depression. The tolerability of ETTS was very good.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abramowitz ES, Bakerk AH, Fleisher SF (1982) Onset of depressive psychiatric crisis and the menstrual cycle. Am J Psychiatry 139:475–478

    PubMed  Google Scholar 

  • AMDP - Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (1981) Das AMDP-System. Manual zur Dokumentation psychiatrischer Befunde, 4. Auflage, Berlin, Heidelberg, New York

  • American Psychiatric Association (1989) Diagnostisches und statistisches Manual psychischer Störungen DSM-III-R. American Psychiatric Association

  • Anderer P, Saletu B, Kinsperger K, Semlitsch H (1987) Topographic brain mapping of EEG in neuropsychopharmacology — part I. Methodological aspects. Methods Find Exp Clin Pharmacol 9 [6]:371–384

    PubMed  Google Scholar 

  • Anderer P, Semlitsch HV, Saletu B, Barbanoj MJ (1992) Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology. Psychiatry Res 45:79–93

    PubMed  Google Scholar 

  • Asso D (1983) The real menstrual cycle. Wiley & Son, Avon

    Google Scholar 

  • Aylward M (1976) Oestrogens, plasma tryptophan levels in perimenopausal patients. In: Campbell S (ed) The management of the menopause and post-menopausal years. University Park Press, Baltimore, pp 135–147

    Google Scholar 

  • Aylward M, Maddock J (1973) Plasma tryptophan levels in depression. Lancet 936

  • Backstrom J (1977) Oestrogen & progesterone in relation to different activities in the central nervous system. Acta Obstet Gynaecol Scand 66:1

    Google Scholar 

  • Ballinger CB, Browning MCK, Smith AHW (1987) Hormone profiles and psychological symptoms in perimenopausal women. Maturitas 9:235–251

    Article  PubMed  Google Scholar 

  • Bartels PH, Subach JA (1976) Automated interpretation of complex scenes. In: Preston E, Onoe M (eds) Digital processing of biomedical imagery. Academic Press, New York, pp 101–114

    Google Scholar 

  • Berner P (1983) Vienna research criteria. In: Berner P, Gabriel E, Katschnig H, Kieffer W, Koehler K, Lenz G, Simhandl Ch (eds) Diagnostic criteria for schizophrenic and affective psychoses. American Psychiatric Press, Washington, pp 157–163

    Google Scholar 

  • Black FW (1975) Unilateral brain lesions and MMPO performance: A preliminary study. Percept Mot Skills 40:87–93

    PubMed  Google Scholar 

  • Campbell S (1976) Double blind psychometric studies on the effects of natural oestrogens on postmenopausal women. In: Campbell S (ed) The management of the menopause and postmenopausal years. MTP Press, Lancaster

    Google Scholar 

  • Chiodo LA, Antelman SM (1980) Tricyclic antidepressants induce subsensitivity of presynaptic dopamine autoreceptors. Eur J Pharmacol 64:203–204

    Article  PubMed  Google Scholar 

  • Chiodo LA, Caggiula AR (1980) Alterations in the basal firing rate and autoreceptor sensitivity of dopamine neurones in the substantia nigra following acute and extended exposure to estrogen. Eur J Pharmacol 67:165–166

    Article  PubMed  Google Scholar 

  • Coope J (1981) Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 31:134–140

    PubMed  Google Scholar 

  • Coope J, Thomson J, Poller L (1975) Effects of natural oestrogen replacement therapy on menopausal symptoms and blood clotting. BMJ J 4:139–143

    Google Scholar 

  • Davidson RJ (1984) Hemispheric asymmetry and emotion. In: Scherer K, Ekman P (eds) Approaches to emotion. Erlbaum, Hillsdale, N.J., pp 39–57

    Google Scholar 

  • Dennerstein L, Burrows GD (1978) A review of studies of the psychological symptoms found at the menopause. Maturitas 1:55–64

    Article  PubMed  Google Scholar 

  • Dennerstein L, Burrows GD, Hyman C, Sharpe K (1979) Hormone therapy and affect. Maturitas 1:247–259

    Article  PubMed  Google Scholar 

  • Depression Guideline Panel (1993) Clinical practice guideline. Depression in primary care: vol. 2. Treatment of major depression. US Dept of Health and Human Services, Agency for Health Care Policy and Research, Rockville, Md.

    Google Scholar 

  • Duffy FH, Bartels PH, Burchfield JL (1981) Significance probability mapping: an aid in the topographic analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol 51:455–462

    Article  PubMed  Google Scholar 

  • Durst N, Maoz B (1979) Changes in psychological well-being during postmenopause as a result of oestrogen therapy. Maturitas 1:301–315

    Article  PubMed  Google Scholar 

  • Ehrenkranz JR (1976) Effect of sex steroids on serotonin uptake in blood platelets. Acta Endocrinol 83:420–428

    PubMed  Google Scholar 

  • Elliott JM, Peters JR, Grahame-Smith DG (1980) Estrogen and progesterone change the binding characteristics of alpha-adrenergic and serotonin receptors on rabbit platelets. Eur J Pharmacol 66:21–30

    Article  PubMed  Google Scholar 

  • Fairchild CJ, Rush J, Vasavada N, Giles DE, Khatami M (1986) Which depressions respond to placebo? Psychiatry Res 18:217–226

    Article  PubMed  Google Scholar 

  • Gainotti G (1972) Emotional behavior and hemispheric side of the lesion. Cortex 8:41–55

    PubMed  Google Scholar 

  • Gasparrini WG, Satz P, Heilman KM, Coolidge FL (1978) Hemispheric asymmetries of affective processing as determined by the Minnesota Multiphasic Personality Inventory. J Neurol Neurosurg Psychiatry 41:470–473

    PubMed  Google Scholar 

  • Gasser T, Bächer P, Möcks J (1982) Transformation towards the normal distribution of broad band spectrum parameters of the EEG. Clin Neurophysiol 43:119–124

    Google Scholar 

  • Gautrey JP, Garrel S, Fau R (1970) Electroencephalographic correlates of the human menstrual cycle. Acta Eur Fertil 2:15–24

    PubMed  Google Scholar 

  • George GCW, Beaumont PJV, Beardwood CJ (1973) Effects of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women. S Afr Med J 47:2387–2394

    PubMed  Google Scholar 

  • George SL (1988) The required size and length of a phase III clinical trial. In: Buyse, Staquet, Sylvester (eds) Cancer clinical trials. Oxford Medical Publications, Oxford

    Google Scholar 

  • Gerdes LC, Sonnendecker EWW, Polakow ES (1982) Psychological changes effects by oestrogen — progestogen and clonidine treatment in climacteric women. Am J Obstet Gynaecol 142:98–104

    Google Scholar 

  • Gonzales GF, Carrillo C (1993) Blood serotonin levels in post-menopausal women: effects of age and serum oestradiol levels. Maturitas 17:23–29

    Article  PubMed  Google Scholar 

  • Gordon JH, Nance DM, Wallis CH, Gorski RA (1977) Effect of estrogen on dopamine turnover, glutamic acid decarboxylase activity and lordosis behavior in septal lesioned female rats. Brain Res Bull 2:341–346

    Article  PubMed  Google Scholar 

  • Grenngrass PM, Tonge SR (1974) The accummulation of noradrenaline and 5-hydroxytryptamine in three regions of mouse brain after tetrabenazine and iproniazid: effects of ethinyloestradiol and prgesterone. Psychopharmacologia 39:187–191

    Article  PubMed  Google Scholar 

  • Hamilton M (1986) HAMD Hamilton Depression Scale. In: CIPS (ed) Internat. Skalen für Psychiatrie. Beltz Test GmbH, Weinheim

    Google Scholar 

  • Henriques JB, Davidson RJ (1990) Regional brain electrical asymmetries discriminate between previously depressed and healthy control subjects. J Abnorm Psychol 99[1]:22–31

    Article  PubMed  Google Scholar 

  • Herrmann WM, Beach RC (1978) The psychotropic properties of estrogens. Pharmakopsychiary 11:164–176

    Google Scholar 

  • Hormone Laboratory, I. Universitäts-Frauenklinik (1989) Normalwerte. Allgemeines Krankenhaus der Stadt Wien, Vienna

    Google Scholar 

  • Hruska RE, Silbergeld EK (1980) Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. Eur J Pharmacol 61:397–400

    Article  PubMed  Google Scholar 

  • Janke W, Debus G (1978) Die Eigenschaftswörterliste EWL. Verlag für Psychologie, Dr. C.J. Hogrefe, Göttingen, Toronto, Zürich

    Google Scholar 

  • Kendall DA, Stancel GM, Enna SJ (1981) Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science 211:1183–1185

    PubMed  Google Scholar 

  • Khan A, Brown WA (1991) Who should receive antidepressants: suggestions from placebo treatment. Psychopharmacol Bull 27:271–274

    PubMed  Google Scholar 

  • Klaiber EL, Kobayashi Y, Broverman DM, Hall F (1971) Plasma monoamine oxidase activity in regularly menstruating women and in amenorrheic women receiving cyclical treatment with estrogens and a progestin. J Clin Endocrinol Metab 33:630–638

    PubMed  Google Scholar 

  • Klaiber EL, Broverman DM, Vogel W (1972) The effects of oestrogen therapy on plasma MAO activity and EEG driving responses of depressed women. Am J Psychiatry 128:1429–1498

    Google Scholar 

  • Klaiber EL, Broverman DM, Vogel W, Kobayashi Y, Moriarty D (1976) The use of steroids in depression. In: Itil TM, Laudahn G, Herrmann WM (eds) The psychotropic effects of hormones. Spectrum Publications, New York

    Google Scholar 

  • Kobayashi T, Kato J (1966) Cholinergic and adrenergic mechanisms in the female rat hypothalamus with special reference to feedback of ovarian steroid hormones. In: Pincus G, Nakao T, Tait J (eds) Steroid dynamics. Academic Press, New York, pp 303–309

    Google Scholar 

  • Kupperman HS (1959) Contemporary therapy of the menopausal syndrome. JAMA 171(12):1627–1637

    PubMed  Google Scholar 

  • Maier W, Benkert O (1986) Placeboeinsatz bei Antidepressivaprüfungen. In: Hippius H, Überla K, Laakmann G, Hasford J (eds) Das Placebo-Problem. Gustav Fischer Verlag, Stuttgart, New York, pp 133–150

    Google Scholar 

  • McEwen BS (1976) Ovarian hormone action in the brain: implications for the menopause. In: Notelovitz M, Van Keep PA (eds) The climacteric in perspective. MTP Press, Lancaster, England, pp 207–209

    Google Scholar 

  • McEwen BS (1988) Basic research perspective: ovarian hormone influence on brain neurochemical function. In: Gise IH (ed) Contemporary issues in obstetrics and gynecology: the premenstrual syndromes. Churchill-Livingstone, New York, pp 21–33

    Google Scholar 

  • McEwen BS, Rhodes JC (1983) Gonadal hormone regulation of MAO and other enzymes in hypothalamic areas. Neuroendocrinology 36:235–238

    PubMed  Google Scholar 

  • McGeer E, McGeer P (1976) Neurotransmitter metabolism in the aging brain. In: Terry RD, Gershon S (eds) Neurobiology of aging, vol. 3. Raven Press, New York, pp 389–391

    Google Scholar 

  • Montgomery JC, Appelby L, Brincat M, Versi E, Tapp A, Fenwick PBC, Studd JWW (1987) Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet I:297–299

    Article  Google Scholar 

  • Oppenheim G (1983) Estrogen in the treatment of depression: neuropharmacological mechanisms. Biological Psychiatry 18[6]:721–725

    PubMed  Google Scholar 

  • Paul SM, Axelrod J, Saavedra JM, Skolnick P (1979) Estrogen-induced efflux of endogenous catecholamines from the hypothalamus in vitro. Brain Res 178:499–505

    Article  PubMed  Google Scholar 

  • Paykel ES, Hollyman JA, Freeling P, Sedgwick P (1988) Predictors of therapeutic benefit from amitriptyline in mild depressions: a general practice placebo-controlled trial. J Affect Disord 14:83–95

    Article  PubMed  Google Scholar 

  • Perini G, Mendius R (1984) Depression and anxiety in complex partial seizures. J Nerv Ment Dis 172:287–290

    PubMed  Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 210:88–90

    PubMed  Google Scholar 

  • Pfaff D, McEwen BS (1983) Action of estrogens and progestins on nerve cells. Science 219:808–814

    PubMed  Google Scholar 

  • Post RM, Gerner RH, Carman TS, Gillin C, Jimerson DC, Goodwin FK, Bunney WE (1978) Effects of a dopamine agonist pirebedil in depressed patients. Arch Gen Psychiatry 35:609–615

    PubMed  Google Scholar 

  • Prange AJ (1972) Estrogen may well affect response to antidepressant. JAMA 219:143–144

    Google Scholar 

  • Rabkin JE, Stewart JW, McGrath PJ, Markowitz JS, Harrison W, Quitkin FM (1987) Baseline characteristics of 10-day placebo washout responders in antidepressant trials. Psychiatry Res 21:9–22

    Article  Google Scholar 

  • Ripley HS, Shorr E, Papanicolaou GN (1940) The effect of treatment of depression in the menopause with estrogenic hormone. Am J Psychiatry 96:905–915

    Google Scholar 

  • Roberts H (1985) The patient patients: women and their doctors, Pandora Press, London

    Google Scholar 

  • Roberts JM, Goldfien RD, Tsuchiya AM, Goldfien A, Insel PA (1979) Estrogen treatment decreases alpha adrenergic binding sites on rabbit platelets. Endocrinology 104:722–728

    PubMed  Google Scholar 

  • Robinson D (1975) Changes in monoamine oxidase and monoamines with human development and aging. Fed Proc 34:103–107

    PubMed  Google Scholar 

  • Robinson RG, Kubos KL, Starr LB, Rao K, Price TR (1984) Mood disorders in stroke patients. Brain 107:81–93

    PubMed  Google Scholar 

  • Sackheim HA, Greenberg MS, Weiman AL, Gur R, Hungerbuhler JP, Geschwind N (1982) Hemispheric asymmetry in the expression of positive and negative emotions. Arch Neurol 39:210–218

    PubMed  Google Scholar 

  • Saletu B, Grünberger J (1985) Memory dysfunction and vigilance: Neurophysiological and psychopharmacological aspects. Ann NY Acad Sci 444:406–427

    PubMed  Google Scholar 

  • Saletu B, Anderer P, Kinsperger K, Grünberger J (1987) Topographic brain mapping of EEG in neuropsychopharmacology – part II. Clinical applications (Pharmaco EEG imaging). Methods Find Exp Clin Pharmacol 9 [6]:385–408

    PubMed  Google Scholar 

  • Saletu B, Küfferle B, Anderer P, Grünberger J, Steinberger K (1990) EEG-brain mapping in schizophrenics with predominatly positive and negative symptoms. Comparative studies with remoxipride/haloperidol. Eur Neuropsychopharmacol 1:27–36

    Article  PubMed  Google Scholar 

  • Saletu B, Küfferle B, Grünberger J, Földes P, Topitz A, Anderer P (1994) Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine. Neuropsychobiology 29:125–135

    PubMed  Google Scholar 

  • Saletu B, Brandstätter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, Heytmanek G, Huber J, Grünberger J, Linzmayer L, Kurz Ch, Decker K, Binder G, Knogler W, Koll B (1995) Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. Maturitas (in press)

  • Sherwin BB (1988) Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345–357

    Article  PubMed  Google Scholar 

  • Sherwin BB, Gelfand MM (1985) Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology 10:325–335

    Article  PubMed  Google Scholar 

  • Sherwin BB, Phillips S (1990) Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 592:474–475

    Google Scholar 

  • Sitruk-Ware R (1993) Percutaneous and transdermal oestrogen replacement therapy. Ann Med 25 [1]:77–82

    PubMed  Google Scholar 

  • Stewart JW, Quitkin FM, Liebowitz MR, McGrath PJ, Harrison WM, Klein DF (1983) Efficacy of desipramine in depressed outpatients: Response according to Research Diagnostic Criteria and severity of illness. Arch Gen Psychiatry 40:202–207

    PubMed  Google Scholar 

  • Stickler RC (1977) The role of oestrogen replacement in the climacteric syndrome. Psychol Med 7:631–637

    PubMed  Google Scholar 

  • Thompson J, Oswald I (1977) Effect of estrogen on the sleep, mood and anxiety of menopausal women. BMJ 2:1317–1319

    PubMed  Google Scholar 

  • Utian WH (1975) Definitive symptoms of post-menopause incorporating use of vaginal parabasal cell index. In: Van Keep PA, Lauritzen C (eds) Frontiers in hormone research: oestrogens in the post-menopause. Karger, Basel

    Google Scholar 

  • Wiklund I, Karlberg J, Mattson L-A (1993) Quality of life of postmenopausal women on a regimen of transdermal oestradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 168 [3/I]:824–830

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria

    B. Saletu, N. Brandstätter, M. Stamenkovic, P. Anderer, H. V. Semlitsch, J. Grünberger, L. Linzmayer, K. Decker & G. Binder

  2. Department of Gynaecology and Obstetrics, University of Vienna, Vienna, Austria

    M. Metka, G. Heytmanek, J. Huber, Ch. Kurz, W. Knogler & B. Koll

Authors
  1. B. Saletu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Brandstätter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Stamenkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Anderer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. V. Semlitsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Grünberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Linzmayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. Decker
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Binder
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Metka
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G. Heytmanek
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Ch. Kurz
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. W. Knogler
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. B. Koll
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saletu, B., Brandstätter, N., Stamenkovic, M. et al. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology 122, 321–329 (1995). https://doi.org/10.1007/BF02246261

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246261

Key words

Search

Navigation